» Download Public Reports
About 100 reports
- Industry report
- February 2013
- 5 pages
... The challenges of proving its efficiency as the preferred destination for global clinical trials. A number of factors favour india as a clinical research hub. Firstly, there are numerous government funded medical ...
January 2013
... A common bond was a tacitly agreed permissiveness - carte blanche for whatever your vision to future progress might be. Crisis in drug discovery Opportunities: Aging population in west More ...
January 2013
... Such as clinical trial conduct and drug safety * biotech products, biosimilars * pharmacogenomics, personalized medicine - increased sourcing * edc/rdc reduce the volume of data management tasks, but make ...
October 2012
... Analytics in clinical studies to drive performance 3 key success factors for establishing strategic partnerships in cdm, bsp and medical writing India as a key destination 8 interview alexander ...
September 2012
... Mn) company overview diagnosearch life sciences (dls) is a full service clinical trials outsourcing company providing its customers with clinical trials and clinical research services ...
August 2012
... For monitoring visits eccro partner clinical trial sites are managed and supported so as to meet our productivity & quality metrics 18 location of eccro office and partner clinical trial sites mumbai eccro ...
August 2012
... Oral insulin project and monoclonal antibodies programs) - which should be translated to shareholder optimism. After years of pioneering drug discovery activity the company is finally seeing the light ...
May 2012
... Unmet needs such as cancer, neurodegeneration, inflammation, diabetes/metabolic disorders, infections and cardiovascular disorders. This opportunity is at the leading edge of drug discovery research ...
April 2012
... drug research. The indian bio Pharmaceutical industry is in its emerging stage and is sized at about $1.4 Billion as of 2010 11. However, indian bio Pharmaceutical players largely market vaccines ...
» Purchase Premium Reports
(From $ 125 - $ 750)
58 reports
- $ 750
- Company report
- May 2013
- by Global Data
Summary Perfint Healthcare Pvt. Ltd. (Perfint) is a medical device company. The company develops medical devices for the healthcare market. Its products include Maxio, Robio EX, Robio EZ and Robio. Robio ...
May 2013
$ 250
Summary Orchid Chemicals & Pharmaceuticals Ltd (Orchid) is a pharmaceutical company, based in India. The company develops and manufactures active pharmaceutical ingredients (APIs) and finished dosage forms ...
March 2013
$ 250
Summary GVK Biosciences Private Limited (GVK BIO) is a contract research organization. The organization provides analytical, biology, chemistry, clinical pharmacology, clinical research, informatics, process ...
April 2013
$ 125
Summary Lupin Limited (Lupin) is transnational pharmaceutical company. The company focuses on the manufacture of generic and branded drugs, formulations and active pharmaceutical ingredients (API's). The ...